Similarly, heterogeneous periodontal case definitions were applied in the included studies, different from the one introduced by the 2017 classification of periodontal and peri-implant diseases and conditions , and, consequently, staging and grading of periodontitis were not performed. In particular, the Community Periodontal Index, employedby Kadhim et al. and by Fernández et al. , is considered jade parcels to be able to detect the prevalence but not the severity of periodontal disease . However, lower CAL values were reported in statin vs. non-statin users by Sayar et al. , who attributed such results to the anti-inflammatory effect exerted by statins, and by Cicek Ari et al., , although not reaching the statistical significance; conversely, opposite results were found by Poston et al. .
Fifth and finally, and related to embracing both impactful and cutting-edge digital health solutions, academic clinical institutions should capitalize on this deluge of data through research and reporting. They should study and report on the efficacy of promising new digital health technologies and approaches, championing the efficacious ones while transparently reporting unsuccessful tools. As noted previously, to be “early adopters” of cutting-edge technologies, the research arms of academic healthcare organizations are well-suited to establish and monitor the impact of digital health technologies.
In addition to Mayo and General Catalyst, other participants in the funding round included Accenture Ventures, NextGen Venture Partners and Dolby Family Ventures. DETROIT, MI—As the service industry begins to embrace the benefits of automation, RoboTirehas raised a$7.5 million Series A round for its tire-changing tech. The round was led by The Reinalt-Thomas Corporation, the major tire retail brand behind Discount Tire and America’s Tire. More specifically, “We struggled with accessing data to improve our models and the precision of the service,” he said.
Examples of evidence-backed approaches that could have digital health approaches include monitoring seizure frequency in epilepsy49, assessment of mood disorders in Parkinson disease50, and patient-reported outcomes in heart failure49–52. All of these examples also represent the collection of health data that may directly lead to changes in care, which affect clinical outcomes. Digital health solutions need not exceed the comparable in-person or traditional care options, but rather produce at least comparable outcomes while improving convenience, access, patient satisfaction, or cost. For example, a televisit is almost always superior to the scheduled in-person visit that never occurs due to transportation, child-care, or other access issues. Gingival crevicular IL-1 wassignificantly lower in statin compared to non-statin users , similarly to MPO and IL-6 levels, opposite to IL-10 ones . Tooth loss may benefit from systemically delivered statins, which may exert a protective effect in periodontal subjects .
Also, few of the original studies described the bacterial pathogen and it was not possible to study the relationship between the pneumonia aetiology and response to adjunct therapies. Previous systematic reviews , including preclinical and animal studies, were focused on the effect of statins, mainly locally delivered ones, on outcomes of periodontitis treatment, without considering comorbidities,other pharmacological treatments and preexisting severity of periodontal tissues disruption. As consumerism across industries creates choice, personalization, and empowerment, patients expect their healthcare experiences to at least match experiences elsewhere. Digital health tools should engage patients through a convenient connected experience that integrates into their lives outside healthcare. This does not imply a “one vendor” or “one technology” approach, which runs counter to innovation. Instead, a systemic approach with deliberate interoperability at data, technology, and patient and provider experience layers.